Through the partnership, the organizations are launching EmsanaRx Plus. The product supplements employers' current pharmacy benefit offerings and provides access to Cost Plus Drugs' discounted medications.
At the 5th annual HLTH conference in Las Vegas, healthcare executives from companies including Jonathan Salon of MDLIVE, responded to questions such as what's the difference between a positive and negative user experience in telehealth? They also previewed their plans for 2023.
There is no fee to apply. Only companies funded from 2018-2022 (no more than five years ago), and that have raised a seed funding round will be considered. Startups can apply to only one track. Startups must be registered for the conference in order to participate in the pitch contest. There are five tracks and each track will feature six finalists. Application Deadline: January 30, 2023. Applications will be reviewed by investment professionals and selections announced on Feb. 21, 2023.
The White House launched a new initiative to address the country's opioid crisis — a dashboard tracking non-fatal opioid overdoses. The new tool is meant to track overdose clusters to inform better medical responses and preparedness.
By Marissa Plescia Thursday, December 8, 2022 6:14 PM
The Food as Medicine movement has received a lot of interest from payers and health systems recently. But employers need to get involved too, argues Dr. Bipin Mistry, chief medical officer of Alight.
The volume of healthcare deals has increased in 2022, driven in large part by private equity, according to a new PwC report. But deal values have been declining, a trend that is expected to continue into 2023.
By Smriti Kirubanandan and Dr. David Katz Thursday, December 8, 2022 1:30 PM
The implications of a ubiquitous diet vital sign are enormous. For example, what can happen if we can measure an upstream variable—such as diet quality—across populations at scale? We can prevent disease, curb the onset of disease, save money, and help health systems improve their bottom lines.
Added complexity to daily life is likely why patient dropout rates remain high, with 19% leaving studies before completion. Truly patient-centric trials will allow for broader participation, allowing patients to decide how and when they want to engage in a study.
Among the takeaways from HLTH 2022 were the impact of consolidation on clinicians, behavioral health tools to help consumers manage stress and anxiety more productively, and how health tech and medtech companies are supporting remote patient monitoring and testing.
MedCity News 611 Broadway New York, NY 10012 United States
You received this email because you are subscribed to MedCity Daily Digest from MedCity News.
Update your email preferences to choose the types of emails you receive.
No comments